ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Inclusion Criteria: * Diagnosis of IPCV * Patients must have had 3 sequential Eylea injections within the previous 4 months Exclusion Criteria: * Intravitreal treatment in the study eye prior to screening, regardless of indication, except 3 prior injections of Eylea * History or evidence of severe cardiac disease * Any major surgical procedure within one month of trial entry * Subjects with a clinically significant laboratory value * Any treatment with an investigational agent in the past 60 days for any condition * Women who are pregnant or nursing * Known serious allergies to the fluorescein dye, ICG dye, iodine, povidone iodine, or to the components or formulation of either Zimura or Eylea